The National Pharmaceutical Pricing Authority (NPPA) on Friday fixed the ceiling prices of 52 formulation packs, all containing at least one of the National List of Essential Medicines (NLEM) defined in specified dosage forms. The packs that are ... Financial Express, 1 week ago
1 images for "ajanta pharma"
The Gujarat market clocked the highest growth rate in pharmaceuticals during November, beating the industry growth rate. According to data from the market research firm AIOCD Pharmasofttech AWACS, Gujarat market grew by 22.4 per cent last month, ...Business Standard India, 1 week ago
NEW DELHI: Sounding a note of caution on Prime Minister Narendra Modi's Make in India campaign, Reserve Bank of India governor Raghuram Rajan on Friday said too much focus on manufacturing and an export-led growth path may not work in India as it ...IPA Newspack.com, 6 days ago
The week ended December 12 remained depressing for equity investors as the key benchmark indices-BSE Sensex and NSE Nifty-tanked 675.80 points and 314.20 points respectively, to 27,350 and 8,224 against 19,350.30 and 8,538.30 on December 5. Market ...Business Today India, 1 week ago
Ajanta Pharma Ltd has announced the Unaudited Standalone financial results for the quarter ended September 30, 2014. The Company has posted a net profit of Rs. 786.30 million for the quarter ended September 30, 2014 as compared to Rs. 558.10 ...Equity Bulls, 1 month ago Ajanta Pharma Q2FY15 results update Stock Markets Review, 1 month ago Ajanta Pharma standalone net profit rises 40.89% in the September 2014 quarter Business Standard, 1 month ago Ajanta Pharma consolidated net surges by 41% in Q2 PharmaBiz, 1 month ago
The Intellectual Property Appellate Board (IPAB) has ordered removal of Clinoxide and Clinoxide-A marks in Class 5 (pharma products), owned by Ajanta Pharma, from the country's trademarks registry as part of settling a dispute between the company ...Financial Express, 1 month ago IPAB orders removal of Ajanta's product TM Business Standard, 1 month ago
Ajanta Pharma has reported results for second quarter ended September 30, 2014. The company has registered 40.89% rise in its net profit at Rs 78.63 crore for the quarter under review as compared to Rs 55.81 crore for the same quarter in the ...Indian-Commodity, 1 month ago Ajanta Pharma surges 5% on solid Q2 India Infoline, 1 month ago
To discuss and understand the issues related to the surprise visits of the WHO certification for schedule M compliance Pharmexcil along with few pharmaceutical industry associations are likely to meet the Maharashtra State FDA commissioner on ...Financial Express, 2 weeks ago
Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...PharmaBiz, 3 weeks ago
Here are Top 10 stocks to focus on September 29 - Bank Nifty, Infosys, Glenmark Pharma, Valecha Engineering, Mayur Uniquoters, Anant Raj Industries, MTNL, Reliance Power, Patel Logistics And Ajanta PharmaMoney Control, 2 months ago Samvat 2071: Top Stock Picks From Brokerages NDTV Profit, 1 month ago Stocks to buy in Samvat 2071 Business Standard India, 1 month ago Samvat 2071: Top Stock Picks NDTV Profit, 1 month ago
on your WebpageAdd Widget >Get your members hooked!